Cargando…

Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study

OBJECTIVES: Few data are available regarding follow up of patients with coronavirus disease 2019 (COVID-19) after their discharge. We aim to describe the long-term outcomes of survivors of hospitalization for COVID-19 followed up first at an outpatient facility and subsequently by telephone. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Meije, Yolanda, Duarte-Borges, Alejandra, Sanz, Xavier, Clemente, Mercedes, Ribera, Alba, Ortega, Lucía, González-Pérez, Ruth, Cid, Roser, Pareja, Júlia, Cantero, Irene, Ariño, Miquel, Sagués, Teresa, LLaberia, Jaume, Ayestarán, Ana, Fernández-Hidalgo, Nuria, Candás-Estébanez, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062910/
https://www.ncbi.nlm.nih.gov/pubmed/33901667
http://dx.doi.org/10.1016/j.cmi.2021.04.002
Descripción
Sumario:OBJECTIVES: Few data are available regarding follow up of patients with coronavirus disease 2019 (COVID-19) after their discharge. We aim to describe the long-term outcomes of survivors of hospitalization for COVID-19 followed up first at an outpatient facility and subsequently by telephone. METHODS: Observational prospective study conducted at a tertiary general hospital. Clinical and radiological progression was assessed and data were recorded on a standardized reporting form. Patients were divided into three groups according to Pao(2)/Fio(2) at hospitalization: Pao(2)/Fio(2) >300, Pao(2)/Fio(2) 300–200 and Pao(2)/Fio(2) <200. A logistic multivariate regression model was performed to identify factors associated with persistence of symptoms. RESULTS: For facility follow up, 302 individuals were enrolled. Median follow up was 45 days after discharge; 78% (228/294) of patients had COVID-19-related symptoms (53% asthenia, 56% respiratory symptoms) and 40% (122/302) had residual pulmonary radiographic lesions. Pao(2)/Fio(2) <200 was an independent predictor of persistent dyspnoea (OR 1.87, 95% CI 1.38–2.52, p < 0.0001). Pao(2)/Fio(2) >300 was associated with resolution of chest radiographic lesions (OR 0.56, 95% CI 0.42–0.74, p < 0.0001). Fifty per cent of patients required specific medical follow up after the first consultation and were transferred to another physician. A total of 294 patients were contacted for telephone follow up after a median follow-up time of 7 months. Fifty per cent of patients (147/294) still presented symptoms and 49% (145/294) had psychological disorders. Asthenia was identified in 27% (78/294) and dyspnoea in 10% (28/294) of patients independently of Pao(2)/Fio(2). CONCLUSIONS: Patients with COVID-19 require long-term follow up because of the persistence of symptoms; patients with low Pao(2)/Fio(2) during the acute illness require special attention.